ATM facility.... They can print shares and sell at the market at the going bid price. They did that in July. I actually think they just did that today with the L5 XT atho trade after hours today.
it looks like we may well have the real thing here, but we can't ignore the fact that double blind trials don't always read out the way holders expect. My inkling (unpopular) is that a CR for 5 million, might be the prudent way to go to ensure the company has a future if the results are mixed. A ordinary readout and we are up the creek. Neuren raised pre trofinetide ph2 and all ended up fine. The trials are blind so there is no correlation between raising cash and trial results.
we wait.
ATH Price at posting:
0.8¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)